Clinical marine biomedicine: An emerging area in clinical and translational medicine

Abstract

Marine biomedicine is an important field in oceanology and bio-ecosystem and has evolved significantly alongside advances in biotechnology and growing understanding of marine life. In this perspective, we propose a refined concept of clinical marine biomedicine, with a clear mission to establish an emerging discipline that bridges marine biomedicine and clinical practice. The exploration of marine-origin sources should be emphasised, with a strong focus on the identification, validation and development of human disease-specific diagnostics and target-oriented pharmaceutics. The perspective headlines some of critical components, including marine-oriented human evolution and development, humanised marine-based models, biomarker innovation and validation, marine microbiomes and metabolites, and target nutrition and therapy. We envision that clinical marine biomedicine will become a crucial pillar clinical molecular medicine, contributing to the improvement of human health and the prognosis of patient.

Keywords

clinical / disease / human / marine biomedicine / oceanology

References

[1] Eales NB. Marine biology research in Great Britain. Nature. 1950; 166(4226): 728-730.

[2] Cheng TC. The (re-)emerging area of marine biomedicine. J Invertebr Pathol. 1982; 40(2): 155-158.

[3] Kohl J. Marine biomedicine: the past, present, and future. Technical Report. 1993.

[4] Chen Y, Zhang X, Peng X, et al. SPEED: single-cell pan-species atlas in the light of ecology and evolution for development and diseases. Nucleic Acids Res. 2023; 51(D1): D1150-D1159.

[5] Li Z, Sun C, Wang F, et al. Molecular mechanisms governing circulating immune cell heterogeneity across different species revealed by single-cell sequencing. Clin Transl Med. 2022; 12(1):e689.

[6] Caley T, Souron A, Uno KT, Macho GA. Climate and human evolution: insights from marine records. Ann Rev Mar Sci. 2025; 17(1): 23-53.

[7] Nelson DR, Mystikou A, Jaiswal A, et al. Macroalgal deep genomics illuminate multiple paths to aquatic, photosynthetic multicellularity. Mol Plant. 2024; 17(5): 747-771.

[8] Albertin CB, Simakov O, Mitros T, et al. The octopus genome and the evolution of cephalopod neural and morphological novelties. Nature. 2015; 524(7564): 220-224.

[9] Liu C, Li R, Li Y, et al. Spatiotemporal mapping of gene expression landscapes and developmental trajectories during zebrafish embryogenesis. Dev Cell. 2022 ; 57(10): 1284-1298.

[10] Saunders LM, Srivatsan SR, Duran M, et al. Embryo-scale reverse genetics at single-cell resolution. Nature. 2023; 623(7988): 782-791.

[11] Wang X, Powell CA, Ma Q, Fan J. Clinical and translational mode of single-cell measurements: an artificial intelligent single-cell. Clin Transl Med. 2024;14(9):e1818.

[12] Hunter MV, Moncada R, Weiss JM, Yanai I, White RM. Spatially resolved transcriptomics reveals the architecture of the tumor‒microenvironment interface. Nat Commun. 2021; 12(1): 6278.

[13] Logares R. Decoding populations in the ocean microbiome. Microbiome. 2024; 12(1): 67.

[14] Paoli L, Ruscheweyh HJ, Forneris CC, et al. Biosynthetic potential of the global ocean microbiome. Nature. 2022; 607(7917): 111-118.

[15] Li H, Dong T, Tao M, et al. Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota. Food Funct. 2024; 15(7): 3463-3478.

[16] Jimenez PC, Wilke DV, Branco PC, et al. Enriching cancer pharmacology with drugs of marine origin. Br J Pharmacol. 2020; 177(1): 3-27.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.